Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
Lisa Zimmer
Consultant or Advisory Role - Bristol-Myers Squibb; Roche
Honoraria - Bristol-Myers Squibb; Novartis; Roche
Other Remuneration - Bristol-Myers Squibb; Roche
Thomas K. Eigentler
Consultant or Advisory Role - Bristol-Myers Squibb; Philogen
Julia-Marianne Vaubel
Honoraria - Bristol-Myers Squibb
Peter Mohr
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; Merck; Novartis; Roche; Scibase
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; Merck; Novartis; Roche; Scibase
Research Funding - Merck
Zeinab Jradi
No relevant relationships to disclose
Felix Kiecker
No relevant relationships to disclose
Jochen Utikal
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Honoraria - Bristol-Myers Squibb; LEO Pharma; MSD; Roche
Carola Berking
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Eckhart Kämpgen
No relevant relationships to disclose
Axel Hauschild
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; MSD; Novartis; OncoSec; Roche
Edgar Dippel
No relevant relationships to disclose
Rainer Rompel
No relevant relationships to disclose
Michael Fluck
Consultant or Advisory Role - MSD; Roche
Honoraria - Bristol-Myers Squibb
Rudolf Stadler
No relevant relationships to disclose
Rudolf Herbst
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Patrick Terheyden
No relevant relationships to disclose
Claus Garbe
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Carmen Loquai
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Dirk Schadendorf
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb